Attached files
Exhibit 23.1
Consent of Independent Registered Public Accounting
Firm
We
hereby consent to the incorporation by reference in the
Registration Statements on Form S-8 (No. 333-167175, 333-196464,
and 333-210182) and on Form S-3 (No. 333-202244, 333-187466, and
333-196468) of our report dated April 2, 2018 included in this
Annual Report on Form 10-K of Tenax Therapeutics, Inc. and
Subsidiary (the “Company”), relating to the
consolidated balance sheets of the Company as of December 31, 2017
and 2016, and the related consolidated statements of operations and
comprehensive loss, stockholders’ equity and cash flows for
each of the years in the two-year period ended December 31,
2017.
/s/ CHERRY BEKAERT LLP
Raleigh,
North Carolina
April
2, 2018